PT1039909E - Metodo de producao e composicao de uma preparacao oral de itraconazole - Google Patents
Metodo de producao e composicao de uma preparacao oral de itraconazoleInfo
- Publication number
- PT1039909E PT1039909E PT98959284T PT98959284T PT1039909E PT 1039909 E PT1039909 E PT 1039909E PT 98959284 T PT98959284 T PT 98959284T PT 98959284 T PT98959284 T PT 98959284T PT 1039909 E PT1039909 E PT 1039909E
- Authority
- PT
- Portugal
- Prior art keywords
- itraconazole
- composition
- production
- oral preparation
- oral
- Prior art date
Links
- VHVPQPYKVGDNFY-ZPGVKDDISA-N itraconazole Chemical compound O=C1N(C(C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-ZPGVKDDISA-N 0.000 title 1
- 229960004130 itraconazole Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19970081947 | 1997-12-31 | ||
KR1019980027730A KR100288890B1 (ko) | 1997-12-31 | 1998-07-10 | 이트라코나졸 경구용 제제 및 그의 제조방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1039909E true PT1039909E (pt) | 2003-02-28 |
Family
ID=26633347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98959284T PT1039909E (pt) | 1997-12-31 | 1998-12-17 | Metodo de producao e composicao de uma preparacao oral de itraconazole |
Country Status (14)
Country | Link |
---|---|
US (1) | US6485743B1 (pt) |
EP (1) | EP1039909B1 (pt) |
JP (1) | JP3696087B2 (pt) |
CN (1) | CN1153570C (pt) |
AU (1) | AU1511399A (pt) |
BR (1) | BR9814729A (pt) |
CA (1) | CA2317106C (pt) |
DE (1) | DE69808670T2 (pt) |
ES (1) | ES2185238T3 (pt) |
HK (1) | HK1034906A1 (pt) |
PL (1) | PL191181B1 (pt) |
PT (1) | PT1039909E (pt) |
TR (1) | TR200001880T2 (pt) |
WO (1) | WO1999033467A1 (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100694667B1 (ko) * | 1999-12-08 | 2007-03-14 | 동아제약주식회사 | 생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제 |
JP5159012B2 (ja) * | 1999-12-23 | 2013-03-06 | メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド | 不良溶解性の薬物に対する改良された医薬組成物 |
FR2803748A1 (fr) * | 2000-01-14 | 2001-07-20 | Ethypharm Lab Prod Ethiques | Composition d'itraconazole et procede de preparation |
KR20010097244A (ko) * | 2000-04-21 | 2001-11-08 | 유충식 | 위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법 |
WO2002055059A2 (en) * | 2000-12-22 | 2002-07-18 | Baxter Int | Method for preparing submicron particle suspensions |
US9700866B2 (en) | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
WO2002100407A1 (en) * | 2001-06-12 | 2002-12-19 | Smartrix Technologies Inc. | Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same |
KR100425755B1 (ko) * | 2001-08-27 | 2004-04-03 | 주식회사 원진신약 | 이트라코나졸을 함유하는 조성물 및 그 제조방법 |
AU2002337692B2 (en) | 2001-09-26 | 2007-09-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
FR2841138B1 (fr) * | 2002-06-25 | 2005-02-25 | Cll Pharma | Composition pharmaceutique solide contenant un principe actif lipophile, son procede de preparation |
JP2005538973A (ja) * | 2002-07-04 | 2005-12-22 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 異なる2種類のポリマーマトリックスを含んで成る固体分散体 |
US20040086567A1 (en) * | 2002-10-30 | 2004-05-06 | Pawan Seth | Bioequivalent composition of itraconazole and a hydrophilic polymer |
DK1438961T4 (da) * | 2003-01-14 | 2014-11-17 | Acino Pharma Ag | Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer |
JP4342426B2 (ja) * | 2004-11-24 | 2009-10-14 | 科研製薬株式会社 | イトラコナゾール経口投与用製剤 |
ES2403006T3 (es) | 2005-08-22 | 2013-05-13 | The Johns Hopkins University | Antagonistas de la vía Hedgehog para tratar enfermedades |
GB0607105D0 (en) * | 2006-04-10 | 2006-05-17 | Leuven K U Res & Dev | Enhancing solubility and dissolution rate of poorly soluble drugs |
US8309129B2 (en) | 2007-05-03 | 2012-11-13 | Bend Research, Inc. | Nanoparticles comprising a drug, ethylcellulose, and a bile salt |
WO2008135855A2 (en) | 2007-05-03 | 2008-11-13 | Pfizer Products Inc. | Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer |
EP2162120B1 (en) | 2007-06-04 | 2016-05-04 | Bend Research, Inc | Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer |
US9545384B2 (en) | 2007-06-04 | 2017-01-17 | Bend Research, Inc. | Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate |
EP2240162A4 (en) | 2007-12-06 | 2013-10-09 | Bend Res Inc | NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER |
US9724362B2 (en) | 2007-12-06 | 2017-08-08 | Bend Research, Inc. | Pharmaceutical compositions comprising nanoparticles and a resuspending material |
KR102009698B1 (ko) | 2011-12-20 | 2019-08-13 | 바이옴 테라퓨틱스 리미티드 | 진균 감염의 치료를 위한 국소 오일 조성물 |
TWI662963B (zh) | 2012-06-04 | 2019-06-21 | 美商製藥有限責任公司 | 布魯頓氏酪胺酸激酶抑制劑之結晶形式 |
WO2013192566A1 (en) | 2012-06-21 | 2013-12-27 | Mayne Pharma International Pty. Ltd. | Itraconazole compositions and dosage forms, and methods of using the same |
EP2983714A2 (en) * | 2013-04-12 | 2016-02-17 | Vyome Biosciences Pvt. Ltd. | Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections |
CN105491886B (zh) * | 2013-08-27 | 2019-01-29 | V·沃道里斯 | 苯达莫司汀医药组合物 |
US10016500B2 (en) * | 2014-03-05 | 2018-07-10 | Professional Compounding Centers Of America | Poloxamer-based pharmaceutical compositions for treating wounds |
MX2017001671A (es) * | 2014-08-07 | 2017-07-04 | Pharmacyclics Llc | Formulaciones novedosas de un inhibidor de la tirosina cinasa de bruton. |
CN104688536B (zh) * | 2015-02-03 | 2016-06-08 | 常州制药厂有限公司 | 一种伊曲康唑制剂的制备方法 |
ES2971597T3 (es) | 2015-03-03 | 2024-06-06 | Pharmacyclics Llc | Formulaciones farmacéuticas del inhibidor de la tirosina quinasa de Bruton |
CN106511265A (zh) * | 2016-11-16 | 2017-03-22 | 北京万全德众医药生物技术有限公司 | 一种含有伊曲康唑的口服溶液及其制备工艺 |
EP3675832A1 (en) | 2017-09-01 | 2020-07-08 | Jordan Sweden Medical and Sterilization Company | Fast self dispersible dosage forms of deferasirox |
CN109172532A (zh) * | 2018-10-24 | 2019-01-11 | 北京哈三联科技有限责任公司 | 一种伊曲康唑分散片及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4267179A (en) | 1978-06-23 | 1981-05-12 | Janssen Pharmaceutica, N.V. | Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles |
JPS57171428A (en) | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
DE3346123A1 (de) | 1983-12-21 | 1985-06-27 | Janssen Pharmaceutica, N.V., Beerse | Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung |
GB8506792D0 (en) | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
JPS63188621A (ja) | 1987-01-30 | 1988-08-04 | Taisho Pharmaceut Co Ltd | 矯味経口製剤 |
JPH0774151B2 (ja) | 1987-10-12 | 1995-08-09 | 三井東圧化学株式会社 | 薬物の好ましくない官能的性質を隠蔽した散剤の製造方法 |
GB8908250D0 (en) | 1989-04-12 | 1989-05-24 | Fisons Plc | Formulations |
JP3034592B2 (ja) | 1990-11-20 | 2000-04-17 | わかもと製薬株式会社 | 経口用固形製剤及びその製造法 |
DK0625899T3 (da) | 1992-02-12 | 1996-06-17 | Janssen Cilag S P A | Liposom-itraconazolformuleringer |
PH30929A (en) * | 1992-09-03 | 1997-12-23 | Janssen Pharmaceutica Nv | Beads having a core coated with an antifungal and a polymer. |
TW438601B (en) | 1994-05-18 | 2001-06-07 | Janssen Pharmaceutica Nv | New mucoadhesive emulsion compositions and a process for the preparation thereof |
FR2722984B1 (fr) | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
US5750147A (en) * | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
HU227745B1 (en) * | 1996-05-20 | 2012-02-28 | Janssen Pharmaceutica Nv | Antifungal compositions containing itraconazole |
-
1998
- 1998-12-17 DE DE69808670T patent/DE69808670T2/de not_active Expired - Lifetime
- 1998-12-17 ES ES98959284T patent/ES2185238T3/es not_active Expired - Lifetime
- 1998-12-17 BR BR9814729-3A patent/BR9814729A/pt not_active Application Discontinuation
- 1998-12-17 AU AU15113/99A patent/AU1511399A/en not_active Abandoned
- 1998-12-17 PT PT98959284T patent/PT1039909E/pt unknown
- 1998-12-17 JP JP2000526224A patent/JP3696087B2/ja not_active Expired - Fee Related
- 1998-12-17 PL PL341566A patent/PL191181B1/pl not_active IP Right Cessation
- 1998-12-17 CA CA002317106A patent/CA2317106C/en not_active Expired - Fee Related
- 1998-12-17 US US09/582,536 patent/US6485743B1/en not_active Expired - Fee Related
- 1998-12-17 EP EP98959284A patent/EP1039909B1/en not_active Expired - Lifetime
- 1998-12-17 WO PCT/KR1998/000436 patent/WO1999033467A1/en active IP Right Grant
- 1998-12-17 CN CNB988128144A patent/CN1153570C/zh not_active Expired - Fee Related
- 1998-12-17 TR TR2000/01880T patent/TR200001880T2/xx unknown
-
2001
- 2001-08-13 HK HK01105615A patent/HK1034906A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1039909B1 (en) | 2002-10-09 |
WO1999033467A1 (en) | 1999-07-08 |
CA2317106C (en) | 2004-11-23 |
ES2185238T3 (es) | 2003-04-16 |
BR9814729A (pt) | 2002-01-08 |
TR200001880T2 (tr) | 2000-11-21 |
HK1034906A1 (en) | 2001-11-09 |
EP1039909A1 (en) | 2000-10-04 |
DE69808670D1 (de) | 2002-11-14 |
AU1511399A (en) | 1999-07-19 |
PL191181B1 (pl) | 2006-03-31 |
PL341566A1 (en) | 2001-04-23 |
CA2317106A1 (en) | 1999-07-08 |
US6485743B1 (en) | 2002-11-26 |
DE69808670T2 (de) | 2003-07-03 |
JP3696087B2 (ja) | 2005-09-14 |
CN1285746A (zh) | 2001-02-28 |
CN1153570C (zh) | 2004-06-16 |
JP2001527044A (ja) | 2001-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1039909E (pt) | Metodo de producao e composicao de uma preparacao oral de itraconazole | |
BR9607791A (pt) | Formulação oral de 2-metil-tieno-benzodiazepina | |
NO994757L (no) | Fremgangsmåte for oral administrasjon av proteiner | |
ID27031A (id) | Komposisi farmasi bersalut enterik dan metode pembuatannya | |
FI972037A0 (fi) | Parannettu menetelmä syötävien pakkausten valmistamiseksi ja koostumuksia niitä varten | |
BR9408540A (pt) | Ferramenta de inserçao e método de produçao de uma ferramenta de inserçao | |
ITMI950529A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
ZA969001B (en) | Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
PT1066027E (pt) | Composicao farmaceutica de topiramato | |
EE200000725A (et) | Uued 3-arüülpropaanhappe derivaadid ja nende analoogid | |
IS5747A (is) | Oxazólidínón afleiður, aðferð fyrir framleiðslu þeirra og lyfjasamsetninga sem innihalda þær | |
IL161542A0 (en) | Composition comprising and method of using angiopoietin-like protein 3 angplt3 | |
IS4635A (is) | 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær | |
EE9800234A (et) | Ravimeetod ja farmatseutiline kompositsioon | |
GB9710800D0 (en) | Pharmaceutical composition and method of preparing it | |
DE59711379D1 (de) | Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren | |
EE04681B1 (et) | 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon | |
ATE308365T1 (de) | Zusammensetzungen zur oralen verabreichung von taxanen und deren verwendung | |
BR9709275A (pt) | Processo de preparação de uma composição sólida e composição sólida | |
PT1023279E (pt) | Compostos e metodo de preparacao de acidos 4-fenil-4-cianociclohexanoicos substituidos | |
BR9510123A (pt) | Composição anabólica da massa óssea | |
ITMI951417A0 (it) | Composizioni farmaceutiche e procedimento per la loro preparazione | |
FI972055A0 (fi) | Syljen analysointimenetelmä | |
ID29104A (id) | Komposisi pemutih kulit untuk pemberian oral | |
IS5077A (is) | Öragna form tetrahýdrópýrídínafleiðu |